The SURMOUNT trials showed tirzepatide at 15 mg achieving 15% to 21% weight loss by week 72, compared to semaglutide at 2.4 mg achieving approximately 15% by week 68
GLP-1s, which have been used for years to treat Type 2 diabetes, have gained widespread attention as a way to lose weight and reduce obesity-related conditions and their long-term costs
Akkor jelentkeznek a leggyakrabban, amikor elszr kezdik el alkalmazni a dulaglutidot, de gyakorisguk a legtbb betegnl idvel cskken
As with many dietary supplements, some individuals may experience occasional digestive discomfort depending on personal sensitivity and individual factors
It suits gym goers who want to burn fat efficiently, endurance athletes who need steady energy, beginners aiming to improve body composition and those who struggle with low workout energy while being on a calorie deficit